Home> Products> gliempaflozin 25 sodium glucose co transporter 2 inhibitors

{ "products": [ { "_id": "683d992c87328f4e892f8716", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "EMPATECH 25", "description": "EMPATECH 25 is an advanced oral medication formulated with Empagliflozin 25 mg, a trusted and effective treatment for managing Type 2 Diabetes Mellitus (T2DM). It is part of a class of drugs known as SGLT2 inhibitors (sodium-glucose co-transporter 2 inhibitors), designed to help lower blood sugar levels in adults when used alongside proper diet and exercise. EMPATECH 25 not only improves glycemic control but also contributes to weight management and cardiovascular health in diabetic patients.\n\nKey Ingredients\nEmpagliflozin 25 mg: A selective SGLT2 inhibitor that helps remove excess glucose from the body through urine, lowering blood sugar levels in patients with type 2 diabetes.\n\nKey Benefits\nHelps significantly reduce elevated blood glucose (HbA1c) levels in Type 2 Diabetes\n\nSupports weight loss by reducing excess sugar stored in the body\n\nAids in lowering systolic blood pressure\n\nDemonstrated cardiovascular benefits, including reduced risk of heart failure hospitalization\n\nEnhances overall glycemic control without causing hypoglycemia when used alone\n\nConvenient once-daily oral dosing\n\nHow Does It Work?\nEmpagliflozin blocks the SGLT2 protein in the kidneys, which is responsible for reabsorbing glucose back into the bloodstream.\n\nBy inhibiting this protein, the medication increases glucose excretion through urine, thereby lowering blood sugar levels.\n\nIt works independently of insulin, making it a suitable option even when insulin resistance is present.\n\nAdditionally, this mechanism reduces blood pressure and body weight, offering multiple metabolic benefits beyond blood sugar control.\n\nDirections for Use\nTake one tablet of EMPATECH 25 orally once a day, preferably at the same time each day.\n\nIt can be taken with or without food.\n\nFollow the dosage as prescribed by your healthcare provider.\n\nDo not crush, chew, or break the tablet; swallow it whole with water.\n\nMaintain regular blood sugar monitoring and adhere to a balanced diet and exercise regimen.\n\nSide Effects\nIncreased urination\n\nGenital infections (e.g., yeast infections)\n\nUrinary tract infections (UTIs)\n\nThirst and mild dehydration\n\nLow blood pressure (especially in people on diuretics)\n\nDizziness or lightheadedness\n\nPossible increase in cholesterol levels\n\nIn rare cases, ketoacidosis (seek immediate medical attention if symptoms like nausea, vomiting, or abdominal pain occur)", "price": 225.0, "discountamount": 68.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": [ "tablet swallow", "day preferably", "body aids", "nausea vomiting", "medical attention", "cholesterol levels", "diuretics dizziness", "crush chew", "healthcare provider", "food follow", "empatech 25 orally", "present additionally", "insulin resistance", "suitable option", "insulin making", "works independently", "sglt2 protein", "causing hypoglycemia", "reduced risk", "cardiovascular health", "weight management", "exercise empatech 25", "effective treatment", "empatech 25empatech 25", "balanced diet", "empagliflozin 25 mg", "glycemic control", "improves glycemic control", "work empagliflozin blocks", "selective sglt2 inhibitor", "alongside proper diet", "abdominal pain occur", "reabsorbing glucose back" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2130, "imageuri": "https://productimages.withfloats.com/actual/683d99313e1ed3094cddca21.png", "tileimageuri": "https://productimages.withfloats.com/tile/683d99313e1ed3094cddca21.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-06-02T12:29:32.123Z", "updatedon": "2025-06-02T12:31:28.199Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/empatech-25/2130", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "Empagliflozin 25 mg", "category": "DIABETIC RANGE", "tags": [ "empagliflozin 25 mg", "empagliflozin 25 mg tablet", "Empagliflozin 25 mg brands in India", "Empagliflozin 25 mg Price in India" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "6890aa548a215c65672372e1", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "EMPATECH LINA 25/5", "description": "EMPATECH LINA 25/5 is a pharmaceutical tablet containing a combination of two active ingredients: Empagliflozin 25MG and Linagliptin 5MG. This medication is designed to help manage blood sugar levels in adults with type 2 diabetes mellitus. The combination works through complementary mechanisms to improve glycemic control more effectively than either drug alone. Empagliflozin is a sodium-glucose cotransporter-2 (SGLT2) inhibitor that promotes the excretion of excess glucose through urine, while Linagliptin is a dipeptidyl peptidase-4 (DPP-4) inhibitor that enhances insulin secretion and suppresses glucagon release, particularly after meals. EMPATECH LINA 25/5 is generally prescribed alongside a balanced diet and regular exercise to optimize blood sugar management and reduce the risk of diabetes-related complications such as kidney damage, neuropathy, and cardiovascular issues.\n\nWhat is EMPATECH LINA 25/5?\n\nEMPATECH LINA 25/5 is a prescription medication combining Empagliflozin (25MG) and Linagliptin (5MG) tablets used to manage type 2 diabetes. It helps control elevated blood sugar levels by using dual actions — the removal of glucose via kidneys and improving pancreatic hormone responses. This combination aims to achieve better and sustained glycemic control, often necessary for patients who have inadequate blood sugar control with other treatments.\n\nUses of EMPATECH LINA 25/5\n\nTo improve blood sugar control in adults with type 2 diabetes, particularly when monotherapy is insufficient.\n\nOften used as a second-line therapy after metformin or when metformin is not tolerated.\n\nTo reduce HbA1c (hemoglobin A1c), an important measure of long-term glucose control.\n\nMay help reduce weight and blood pressure as empagliflozin aids in glucose excretion.\n\nSupports comprehensive diabetes management along with diet and exercise.\n\nPrevents or reduces the risk of diabetes-associated complications such as kidney disease, cardiovascular events, and nerve damage.\n\nSide Effects of EMPATECH LINA 25/5\n\nCommon side effects may include urinary tract infections and genital infections due to increased glucose in urine.\n\nIncreased urination and dehydration.\n\nDizziness or lightheadedness, especially when standing up quickly.\n\nHypoglycemia (low blood sugar), though rare with this combination.\n\nGastrointestinal symptoms such as nausea or diarrhea.\n\nPotential increased risk of ketoacidosis (a serious condition related to high blood acids) in rare cases.\n\nAllergic reactions, although uncommon, may occur and require prompt medical attention.\n\nPrecautions Before Using EMPATECH LINA 25/5\n\nInform your healthcare provider if you have kidney disease, liver problems, or a history of urinary tract infections.\n\nNot recommended for type 1 diabetes or diabetic ketoacidosis treatment.\n\nUse with caution if you are pregnant, planning to become pregnant, or breastfeeding.\n\nStay hydrated while on this medication to reduce the risk of dehydration and dizziness.\n\nInform your doctor about any history of pancreatitis or pancreas disorders.\n\nRegular monitoring of kidney function and blood sugar levels is advised during treatment.\n\nAvoid drinking excessive alcohol as it may increase side effects or risk of ketoacidosis.\n\nDrug Interactions: What Drugs Interact with EMPATECH LINA 25/5?\n\nOther antidiabetic medications, such as insulin or sulfonylureas, may increase the risk of hypoglycemia.\n\nDiuretics, blood pressure medications, and lithium may interact and increase side effects.\n\nDrugs that impair kidney function can affect empagliflozin’s efficacy and safety.\n\nCertain enzyme-inducing drugs may reduce linagliptin levels, lowering its effectiveness.\n\nConsult your healthcare provider for a full list of possible interactions and before starting any new medication, including over-the-counter drugs or supplements.\n\nConclusion\n\nEMPATECH LINA 25/5, containing Empagliflozin 25MG and Linagliptin 5MG, is an effective combination medication to treat high blood sugar levels caused by type 2 diabetes. Its dual-action approach targets different physiological mechanisms to improve blood glucose control, helping reduce the risks and complications associated with diabetes. While it is generally well-tolerated, awareness of possible side effects and drug interactions is important. Always use under medical supervision, alongside lifestyle modifications such as diet and exercise, for optimal diabetes management.", "price": 345.0, "discountamount": 104.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2154, "imageuri": "https://productimages.withfloats.com/actual/6890aa58dd0bc098c3220f4c.png", "tileimageuri": "https://productimages.withfloats.com/tile/6890aa58dd0bc098c3220f4c.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-08-04T12:40:52.619Z", "updatedon": "2025-08-04T12:40:52.619Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/empatech-lina-25-5/2154", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "Empagliflozin and Linagliptin Tablets", "category": "DIABETIC RANGE", "tags": [ "Empagliflozin and Linagliptin Tablets" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "67a35c945c5e728a14d08ad8", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Empagliflozin (25mg), Linagliptin (5mg)", "description": "GLIEMPAFLOZIN LINA 25mg/5mg is a combination medication designed for individuals managing type 2 diabetes mellitus. It contains Empagliflozin (25mg) and Linagliptin (5mg), two potent anti-diabetic agents that work together to control blood sugar levels effectively. This medication is typically prescribed to patients who require dual therapy to achieve optimal glycemic control when diet and exercise alone are insufficient.\n\n \nKey Benefits :\n \n\nEffective Blood Sugar Control: Regulates blood glucose levels efficiently in patients with type 2 diabetes.\n\nWeight Management: Empagliflozin promotes weight loss by removing excess glucose from the body.\n\nHeart and Kidney Benefits: Shown to provide cardiovascular and renal protection, reducing the risk of heart failure.\n\nLower Risk of Hypoglycemia: Minimal chances of low blood sugar episodes compared to other anti-diabetic medications.\n\nConvenient Dual Therapy: Combines two complementary mechanisms for enhanced glycemic control in a single tablet.\n\n \nHow Does It Work?\n \n\nEmpagliflozin (SGLT2 Inhibitor): This component blocks Sodium-Glucose Cotransporter-2 (SGLT2) in the kidneys, preventing glucose reabsorption and facilitating its elimination through urine. This leads to a significant reduction in blood sugar levels.\n\nLinagliptin (DPP-4 Inhibitor): It inhibits Dipeptidyl Peptidase-4 (DPP-4) enzyme, which increases incretin hormone levels. This enhances insulin secretion and suppresses glucagon production, leading to better post-meal glucose control.\n\n \nDirections for Use\n \n\nTake one tablet daily, preferably at the same time each day.\n\nSwallow the tablet whole with water, with or without food.\n\nFollow the dosage regimen prescribed by your healthcare provider.\n\nRegular monitoring of blood sugar levels is recommended.\n\n \nSide Effects\n \n\nAlthough GLIEMPAFLOZIN LINA 25mg/5mg is generally well-tolerated, some patients may experience:\n\nFrequent Urination: Due to glucose excretion through urine.\n\nDehydration or Thirst: Increased urination may lead to mild dehydration.\n\nUrinary Tract Infections (UTIs): A common side effect associated with SGLT2 inhibitors.\n\nNasal Congestion or Sore Throat: Occasionally observed with DPP-4 inhibitors.\n\nGastrointestinal Discomfort: Mild nausea or diarrhea in some cases.\n\nHypotension (Low Blood Pressure): Especially in patients with pre-existing conditions.\n\n ", "price": 345.0, "discountamount": 104.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": [ "urine dehydration", "preexisting conditions", "generally welltolerated", "food follow", "day swallow", "significant reduction", "single tablet", "complementary mechanisms", "provide cardiovascular", "body heart", "linagliptin 5mg", "empagliflozin 25mg", "glucose excretion", "typically prescribed", "tablet daily preferably", "combination medication designed", "dosage regimen prescribed", "removing excess glucose", "common side effect", "thirst increased urination", "gliempaflozin lina 25mg5mg", "recommended side effects", "blood sugar levels", "enhances insulin secretion", "enhanced glycemic control", "hypoglycemia minimal chances", "renal protection reducing", "kidney benefits shown", "require dual therapy", "potent antidiabetic agents" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2048, "imageuri": "https://productimages.withfloats.com/actual/67a35cb9b07d7c125c0f536d.png", "tileimageuri": "https://productimages.withfloats.com/tile/67a35cb9b07d7c125c0f536d.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-02-05T12:41:56.39Z", "updatedon": "2025-03-17T11:04:56.55Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/empagliflozin-25mg-linagliptin-5mg-/2048", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "GLIEMPAFLOZIN LINA 25mg/ 5mg", "category": "DIABETIC RANGE", "tags": [ "empagliflozin-linagliptin 25-5 mg price", "Empagliflozin and Linagliptin brands in India", "empagliflozin-linagliptin 10-5 mg", "Fixed dose combination of Empagliflozin and Linagliptin Tablets Price" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "68949d4ea0059029dc8c8915", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "BENZTETRA 25", "description": "BENZTETRA 25 contains the active ingredient tetrabenazine 25mg, a specialized medication used primarily to manage involuntary movements associated with neurological disorders. Tetrabenazine is classified as a vesicular monoamine transporter 2 (VMAT2) inhibitor and works by regulating the levels of neurotransmitters such as dopamine, serotonin, norepinephrine, and histamine in the brain. This correction of chemical imbalances helps reduce excessive and uncontrolled muscle movements. BENZTETRA 25 is especially valuable for patients suffering from movement disorders that significantly impact their daily functioning. It helps improve motor control, thereby enhancing quality of life for those affected. This medication is prescribed mainly to treat chorea—a movement disorder characterized by jerky, irregular, and uncontrollable muscle movements—that is caused by Huntington disease.\n\nWhat is BENZTETRA 25?\nBENZTETRA 25 is a therapeutic tablet containing tetrabenazine 25mg, designed to treat involuntary movements (chorea) linked to Huntington disease. It does not cure Huntington disease nor address cognitive or psychiatric symptoms of the disease but effectively reduces the severity of abnormal movements by altering neurotransmitter activity in the brain.\n\nUses of BENZTETRA 25\n\nTo treat chorea (a movement disorder) that is caused by Huntington disease.\n\nTo control involuntary muscle movements in Huntington’s disease patients.\n\nManagement of other hyperkinetic movement disorders as determined by a healthcare provider (such as tardive dyskinesia or Tourette syndrome in some cases).\n\nTo reduce excessive motor activity caused by abnormal nerve signaling in the brain, improving voluntary muscle control.\n\nSide Effects of BENZTETRA 25\n\nDrowsiness and fatigue, which may affect alertness.\n\nInsomnia or difficulty sleeping.\n\nNausea, vomiting, or abdominal discomfort.\n\nParkinsonism symptoms such as tremors, muscle rigidity, and slowed movements (bradykinesia).\n\nMood alterations including depression, anxiety, and in severe cases, suicidal thoughts.\n\nRare serious reactions like allergic responses, heart rhythm irregularities, or neuroleptic malignant syndrome (characterized by high fever, muscle stiffness).\n\nPrecautions Before Using BENZTETRA 25\n\nInform your doctor if you have a history of depression, suicidal thoughts, or any psychiatric illness.\n\nAvoid use if you have severe liver disease or have recently taken monoamine oxidase inhibitors (MAOIs).\n\nCaution in patients with cardiac issues due to potential QT interval prolongation.\n\nUse with care when driving or operating machinery as BENZTETRA 25 may cause dizziness or drowsiness.\n\nDo not stop the medication suddenly without consulting your healthcare provider, as symptoms might worsen.\n\nRegular monitoring by a healthcare professional is recommended to assess side effects and efficacy.\n\nDrug Interactions: What Drugs Interact with BENZTETRA 25?\n\nMAO inhibitors such as isocarboxazid, phenelzine, selegiline, and others can cause dangerous interactions and should not be used concurrently.\n\nOther drugs that affect serotonin levels, including selective serotonin reuptake inhibitors (SSRIs), may increase the risk of serotonin syndrome.\n\nCaution with other medications known to prolong the QT interval or those affecting dopamine systems.\n\nInteractions with neuroleptics or antipsychotics require close medical supervision due to additive effects on movement and mood.\n\nConclusion\nBENZTETRA 25, containing tetrabenazine 25mg, is a vital medication for managing chorea associated with Huntington disease by modulating neurotransmitter levels in the brain to reduce involuntary movements. While it offers substantial benefits in improving motor control, careful attention to side effects, precautions, and drug interactions is essential for safe and effective use. Always follow the guidance of a healthcare professional when using BENZTETRA 25 to ensure optimal outcomes and safety.", "price": 425.0, "discountamount": 128.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2158, "imageuri": "https://productimages.withfloats.com/actual/68949d54c82f93461bdc841f.png", "tileimageuri": "https://productimages.withfloats.com/tile/68949d54c82f93461bdc841f.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-08-07T12:34:22.411Z", "updatedon": "2025-08-07T12:34:22.411Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/benztetra-25/2158", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "tetrabenazine 25mg", "category": "NEUROLOGY RANGE", "tags": [ "tetrabenazine 25mg" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "67a35850f802c8856080561d", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Empagliflozin (25mg)", "description": "GLIEMPAFLOZIN 25 is an oral anti-diabetic medication used to manage Type 2 diabetes mellitus by helping control blood sugar levels. It belongs to the SGLT2 inhibitors (Sodium-Glucose Co-Transporter-2 inhibitors) class, which works by promoting glucose excretion through urine. This helps in lowering blood glucose levels and improving glycemic control in diabetic patients. Additionally, it may reduce the risk of cardiovascular complications in individuals with diabetes.\n\n \nKey Benefits:\n \n\nEffective Blood Sugar Control – Helps in reducing high blood sugar levels in Type 2 diabetes mellitus patients.\nPromotes Weight Loss – Encourages calorie loss through glucose excretion, which may aid in weight management.\nCardiovascular Protection – Studies suggest it may help reduce the risk of heart failure and cardiovascular diseases in diabetic patients.\nSupports Kidney Health – Can help slow down the progression of diabetic kidney disease.\nReduces Blood Pressure – Helps in lowering blood pressure, especially in diabetic individuals with hypertension.\nLowers Risk of Hypoglycemia – Since it works independently of insulin, the risk of dangerously low blood sugar levels is minimized.\n \nHow Does It Work?\n \n\nGLIEMPAFLOZIN 25 works by blocking the SGLT2 protein in the kidneys, which is responsible for glucose reabsorption. By inhibiting this protein, the medication promotes the excretion of excess glucose through urine, reducing blood sugar levels. This mechanism also leads to a mild diuretic effect, which may help in lowering blood pressure and aiding weight loss.\n\n \nDirections for Use:\n \n\nTake one tablet daily or as directed by your healthcare provider.\nSwallow the tablet whole with water, with or without food.\nFollow a balanced diet and exercise routine to enhance effectiveness.\nRegularly monitor blood sugar levels as per your doctor’s advice.\n \nSide Effects:\n \n\nWhile GLIEMPAFLOZIN 25 is generally well-tolerated, some individuals may experience mild to moderate side effects, including:\n\nIncreased urination\nUrinary tract infections (UTIs)\n Genital infections (e.g., yeast infections)\nDehydration or dizziness\nLow blood pressure\nIncreased thirst\nKetoacidosis (rare but serious)\nIf you experience severe allergic reactions, persistent infections, or unusual symptoms, consult your healthcare provider immediately.", "price": 225.0, "discountamount": 68.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": [ "gliempaflozin 25", "tablet daily", "sglt2 protein", "works independently", "diabetic individuals", "generally welltolerated", "exercise routine", "balanced diet", "food follow", "cardiovascular diseases", "heart failure", "cardiovascular complications", "empagliflozin 25mggliempaflozin 25", "excess glucose", "glucose reabsorption", "glucose excretion", "experience mild", "medication promotes", "promoting glucose excretion", "hypertension lowers risk", "mild diuretic effect", "diabetic patients additionally", "oral antidiabetic medication", "healthcare provider immediately", "unusual symptoms consult", "yeast infections dehydration", "moderate side effects", "healthcare provider swallow", "lowering blood pressure", "improving glycemic control" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2044, "imageuri": "https://productimages.withfloats.com/actual/67a35882b85688fc926014d2.png", "tileimageuri": "https://productimages.withfloats.com/tile/67a35882b85688fc926014d2.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-02-05T12:23:44.164Z", "updatedon": "2025-03-17T11:07:38.155Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/empagliflozin-25mg-/2044", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "GLIEMPAFLOZIN 25 ", "category": "DIABETIC RANGE", "tags": [ "Empagliflozin 25 mg brands in India", "Empagliflozin 25 mg price in India", "Empagliflozin 25 mg uses", "Empagliflozin 25 mg substitute", "Empagliflozin dose 25 mg" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "66ed2340847254d7d1081d9a", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Sitagliptin Tablet IP 25 mg", "description": "ST GLIPTIN 25 is a pharmaceutical product containing Sitagliptin, an effective medication used to control blood sugar levels in individuals with Type 2 diabetes mellitus. It belongs to a class of drugs known as DPP-4 inhibitors (dipeptidyl peptidase-4 inhibitors). This medication is often prescribed in combination with other antidiabetic drugs or diet and exercise plans to help manage blood sugar levels and reduce the risk of complications associated with diabetes, such as heart disease, nerve damage, and kidney problems.\n\n \nKey Ingredients:\n \n\nSitagliptin Tablet IP 25 mg: The active ingredient Sitagliptin works by increasing the levels of incretin hormones, which help regulate insulin production in response to meals. It also lowers the amount of glucose produced by the liver.\n \nKey Benefits:\n \n\nEffective Blood Sugar Control: ST GLIPTIN 25 helps to manage blood sugar levels in adults with Type 2 diabetes, especially when used alongside proper diet and exercise.\nMinimal Risk of Hypoglycemia: Unlike some other diabetes medications, Sitagliptin generally does not cause hypoglycemia (low blood sugar) when used alone.\nPromotes Healthy Insulin Levels: Sitagliptin helps enhance the body’s natural release of insulin after meals, improving overall glucose management.\nSupports Heart Health: Maintaining stable blood sugar levels can reduce the risk of cardiovascular complications, making it an important part of a diabetes management plan.\n \nHow Does It Work?\n \n\nST GLIPTIN 25 (Sitagliptin) works by inhibiting the DPP-4 enzyme, which is responsible for breaking down incretin hormones. These hormones play a key role in regulating blood glucose levels by stimulating insulin release and decreasing glucose production in the liver. By inhibiting DPP-4, Sitagliptin increases the levels of active incretin hormones, leading to better control over blood sugar levels, especially after meals.\n\n \nDirections for Use:\n \n\nDosage: The recommended dose is typically 25 mg taken once daily, as directed by your healthcare provider. This dosage may be adjusted based on the individual's health condition and response to treatment.\nMethod: ST GLIPTIN 25 can be taken with or without food. Swallow the tablet whole with a glass of water. To achieve the best results, it's important to take the medication at the same time each day.\nConsistency: It's essential to continue taking ST GLIPTIN 25 as prescribed, even if you feel well. Do not stop the medication without consulting your doctor.\n \nSide Effects:\n \n\nWhile ST GLIPTIN 25 is generally well-tolerated, some individuals may experience side effects such as:\n\nNausea or diarrhea\nHeadache\nUpper respiratory tract infections\nSore throat\nJoint pain", "price": 69.0, "discountamount": 20.7, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "key role", "same time", "Joint pain", "ST GLIPTIN", "proper diet", "Sore throat", "Minimal Risk", "DPP-4 enzyme", "Side Effects", "best results", "Heart Health", "Key Benefits", "nerve damage", "heart disease", "exercise plans", "insulin release", "natural release", "Key Ingredients", "kidney problems", "low blood sugar", "health condition", "DPP-4 inhibitors", "active ingredient", "insulin production", "glucose production", "healthcare provider", "effective medication", "blood glucose levels", "Sitagliptin Tablet IP", "pharmaceutical product", "Healthy Insulin Levels", "active incretin hormones", "Type 2 diabetes mellitus", "other antidiabetic drugs", "diabetes management plan", "stable blood sugar levels", "overall glucose management", "other diabetes medications", "cardiovascular complications", "Effective Blood Sugar Control", "dipeptidyl peptidase-4 inhibitors", "Upper respiratory tract infections" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1978, "imageuri": "https://productimages.withfloats.com/actual/66ed23433e1478b5013cfd1c.png", "tileimageuri": "https://productimages.withfloats.com/tile/66ed23433e1478b5013cfd1c.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-09-20T07:24:48.197Z", "updatedon": "2024-09-20T07:28:37.557Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/sitagliptin-tablet-ip-25-mg/1978", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "ST GLIPTIN 25 ", "category": "DIABETIC RANGE", "tags": [ "What is gliptin used for?", "", "What is the use of S gliptin tablet?" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "666053368e599e12c0ea9a06", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "PAFAGOLD 5 ", "description": "PAFAGOLD 5 \nDapagliflozin (5mg)\nIntroduction to PAFAGOLD 5\nPAFAGOLD 5 contains Dapagliflozin 5mg, a medication used primarily for the management of type 2 diabetes mellitus. Dapagliflozin belongs to a class of drugs known as SGLT2 (sodium-glucose co-transporter-2) inhibitors. It helps improve blood sugar control by preventing the kidneys from reabsorbing glucose back into the blood, allowing glucose to be excreted in the urine. This medication is typically used in combination with diet and exercise to improve glycemic control in adults with type 2 diabetes.\n\nWhat is Dapagliflozin?\nOverview of Dapagliflozin\nDapagliflozin is an SGLT2 inhibitor that works by blocking the reabsorption of glucose in the kidneys. This leads to the excretion of excess glucose through urine, thereby lowering blood sugar levels. Dapagliflozin also offers additional benefits such as weight loss and cardiovascular protection.\n\nMechanism of Action\nSGLT2 Inhibition: Dapagliflozin inhibits the SGLT2 protein in the kidneys, responsible for reabsorbing glucose back into the bloodstream. By blocking this protein, Dapagliflozin ensures that excess glucose is excreted in the urine.\nBlood Sugar Reduction: This mechanism helps lower blood sugar levels, particularly fasting blood glucose levels, contributing to overall glycemic control.\nBenefits of PAFAGOLD 5\nEffective Blood Sugar Management\nFasting Glucose Control: PAFAGOLD 5 helps lower fasting blood glucose levels by promoting the excretion of glucose through urine.\nComprehensive Glycemic Control: By targeting glucose reabsorption in the kidneys, Dapagliflozin provides a unique mechanism of action that complements other diabetes medications, offering comprehensive blood sugar management.\nSupport for Diabetes Management\nDiet and Exercise Adjunct: PAFAGOLD 5 is an excellent adjunct to diet and exercise, helping patients achieve better blood sugar control when lifestyle modifications alone are insufficient.\nReduced Risk of Complications: By maintaining more stable blood sugar levels, PAFAGOLD 5 can help reduce the risk of long-term complications associated with diabetes, such as cardiovascular disease, neuropathy, and retinopathy.\nAdditional Health Benefits\nWeight Management: Dapagliflozin has been associated with weight loss due to the excretion of glucose and calories in the urine.\nCardiovascular Protection: SGLT2 inhibitors like Dapagliflozin have been shown to provide cardiovascular benefits, reducing the risk of heart failure and other cardiovascular events in diabetic patients.\nHow to Use PAFAGOLD 5\nDosage and Administration\nRecommended Dosage: The typical dosage of PAFAGOLD 5 is one tablet taken once daily. Your healthcare provider may adjust the dosage based on your individual response and blood sugar levels.\nAdministration: Take the tablet with or without food. Swallow the tablet whole with a full glass of water. Consistency is key, so take the medication at the same time each day.\nGuidelines for Optimal Use\nConsistent Use: For best results, take PAFAGOLD 5 regularly as prescribed by your healthcare provider.\nMonitor Blood Sugar Levels: Regularly check your blood sugar levels to ensure the medication is effectively controlling your diabetes. Adjustments to your treatment plan may be necessary based on these readings.\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order Now\nhttps://www.sterisonline.com/product/pafagold-5-134125", "price": 120.0, "discountamount": 36.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "diet", "food", "drugs", "urine", "class", "EMAIL", "Order", "water", "adults", "Action", "kidneys", "Support", "calories", "PAFAGOLD", "readings", "Overview", "excretion", "same time", "Guidelines", "one tablet", "full glass", "neuropathy", "Consistency", "bloodstream", "Adjustments", "weight loss", "information", "retinopathy", "combination", "Optimal Use", "Introduction", "sterisonline", "best results", "sterispharma", "Reduced Risk", "heart failure", "SGLT2 protein", "CALL/WHATSAPP", "Administration", "sodium-glucose", "typical dosage", "treatment plan", "Consistent Use", "excess glucose", "SGLT2 inhibitor", "Exercise Adjunct", "SGLT2 Inhibition", "unique mechanism", "Dapagliflozin 5mg", "Weight Management", "diabetic patients", "excellent adjunct", "Recommended Dosage", "individual response", "healthcare provider", "blood sugar control", "Diabetes Management", "additional benefits", "glucose reabsorption", "blood glucose levels", "Blood Sugar Reduction", "cardiovascular disease", "cardiovascular benefits", "Fasting Glucose Control", "lifestyle modifications", "long-term complications", "type 2 diabetes mellitus", "overall glycemic control", "transporter-2) inhibitors", "cardiovascular protection", "stable blood sugar levels", "Additional Health Benefits", "other diabetes medications", "other cardiovascular events", "Comprehensive Glycemic Control", "Effective Blood Sugar Management", "comprehensive blood sugar management" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1388, "imageuri": "https://productimages.withfloats.com/actual/666053389917812fea5771aa.png", "tileimageuri": "https://productimages.withfloats.com/tile/666053389917812fea5771aa.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-05T11:59:50.713Z", "updatedon": "2024-06-29T11:06:57.321Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/pafagold-5-/1388", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "PAFAGOLD 5 ", "category": "DIABETIC RANGE", "tags": [ "PAFAGOLD 5", "Dapagliflozin (5mg)", "Dapagliflozin 5 mg uses", "Dapagliflozin 5 mg price", "Dapagliflozin 5 mg dosage", "Dapagliflozin 5 mg substitute" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "67e151dde76674b1ca044d32", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Empagliflozin 25 mg and Sitagliptin 100 mg", "description": "GLIEMPAFLOZIN SITA 25/100 is an advanced anti-diabetic medication containing Empagliflozin 25 mg and Sitagliptin 100 mg, formulated to effectively control blood sugar levels in individuals with Type 2 Diabetes Mellitus. This powerful combination helps regulate glucose levels, improve insulin function, and reduce the risk of diabetes-related complications. It is designed for patients requiring dual therapy to achieve better glycemic control.\n\n \nKey Benefits:\n \nEffective Blood Sugar Control – Lowers HbA1c levels and maintains long-term glycemic stability.\nPromotes Weight Loss – Empagliflozin helps in reducing excess body weight by eliminating excess glucose.\nHeart & Kidney Protection – Reduces the risk of cardiovascular diseases and kidney complications.\nEnhanced Insulin Sensitivity – Improves insulin response and minimizes glucose spikes.\nConvenient Dual Therapy – Combines two powerful anti-diabetic agents in one tablet for better diabetes management.\n\n \nHow Does It Work?\n \n\nEmpagliflozin blocks the SGLT2 protein in the kidneys, preventing glucose reabsorption and promoting glucose excretion through urine. This helps lower blood sugar levels naturally while supporting heart and kidney health.\n\nSitagliptin works by inhibiting the DPP-4 enzyme, which increases the levels of incretin hormones that stimulate insulin release and reduce glucose production in the liver.\n\nTogether, they offer comprehensive diabetes control by lowering blood sugar through different mechanisms, making it a superior option for Type 2 Diabetes management.\n\n \nDirections for Use:\n \n\nTake GLIEMPAFLOZIN SITA 25/100 as prescribed by your doctor.\n\nSwallow the tablet whole with water, preferably once daily with or without food.\n\nMaintain a healthy diet and regular exercise for best results.\n\nDo not exceed the recommended dosage without consulting a healthcare professional.\n\n \nSide Effects:\n \n\nWhile generally well-tolerated, some users may experience:\n\nFrequent Urination (due to glucose excretion)\nDehydration & Dizziness\nMild Nausea or Stomach Discomfort\nHypoglycemia (Low Blood Sugar) – Especially if combined with insulin or sulfonylureas\nUrinary or Genital Infections (due to increased sugar excretion in urine)\n\nSeek medical attention if you experience severe allergic reactions, persistent dizziness, or signs of dehydration.", "price": 425.0, "discountamount": 128.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": [ "sulfonylureas urinary", "generally welltolerated", "recommended dosage", "regular exercise", "healthy diet", "food maintain", "water preferably", "doctor swallow", "gliempaflozin sita 25100", "superior option", "mechanisms making", "incretin hormones", "dpp4 enzyme", "supporting heart", "sglt2 protein", "diabetes management", "cardiovascular diseases", "diabetesrelated complications", "empagliflozin 25mg", "reduce glucose production", "stimulate insulin release", "work empagliflozin blocks", "increased sugar excretion", "genital infections due", "lowering blood sugar", "promoting glucose excretion", "powerful antidiabetic agents", "sitagliptin 100mg formulated", "advanced antidiabetic medication" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2071, "imageuri": "https://productimages.withfloats.com/actual/67e151f4a5330495f6fabda3.png", "tileimageuri": "https://productimages.withfloats.com/tile/67e151f4a5330495f6fabda3.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-03-24T12:36:45.699Z", "updatedon": "2025-03-27T13:02:48.654Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/empagliflozin-25-mg-and-sitagliptin-100-mg/2071", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "GLIEMPAFLOZIN SITA 25/100", "category": "DIABETIC RANGE", "tags": [ "Empagliflozin and sitagliptin combination", "Empagliflozin 25 mg substitute", "Empagliflozin 25 mg brands in India", "Empagliflozin 25 mg Price in India", "Empagliflozin brands in India", "Empagliflozin 25 mg", "Empagliflozin" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "671b8c4b0f43c08f3cf6505f", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Ramipril (1.25 mg)", "description": "REMINIL 1.25 is a medication containing Ramipril (1.25 mg), primarily prescribed for managing high blood pressure and reducing the risk of heart-related conditions such as heart attacks and strokes. As part of the angiotensin-converting enzyme (ACE) inhibitor class, REMINIL 1.25 helps to regulate blood pressure, offering a reliable solution for those needing long-term heart health and blood pressure control.\n\n \n\nKey Benefits:\n \n\nRegulates Blood Pressure: REMINIL 1.25 is effective in reducing high blood pressure, which helps lower the risk of heart disease, kidney complications, and stroke.\n\nImproves Heart Function: By relaxing blood vessels, REMINIL 1.25 makes it easier for the heart to pump blood, thereby supporting overall heart health and reducing strain on the heart muscle.\n\nReduces Risk of Heart-Related Conditions: This medication is commonly prescribed to prevent complications in patients with an increased risk of heart attacks and strokes.\n\nKidney Protection: For individuals with diabetes or other kidney-related concerns, REMINIL 1.25 can help protect the kidneys from damage associated with high blood pressure.\n\n \n\nHow Does It Work?\n \nREMINIL 1.25 works by inhibiting the action of angiotensin-converting enzyme (ACE), which is responsible for the production of angiotensin II—a hormone that causes blood vessels to constrict. By blocking ACE, REMINIL 1.25 decreases the levels of angiotensin II, leading to the relaxation of blood vessels and lowering blood pressure. This relaxed state of blood vessels improves blood flow, making it easier for the heart to pump blood, and reduces the risk of hypertension-related complications.\n\n \n\nDirections for Use:\n \nDosage: Take REMINIL 1.25 as prescribed by your healthcare provider, usually once daily.\n\nAdministration: Swallow the tablet whole with water, preferably at the same time each day to maintain consistent blood levels.\n\nWith or Without Food: REMINIL 1.25 can be taken with or without food, but it's advised to follow your doctor’s instructions closely.\n\nMissed Dose: If you miss a dose, take it as soon as you remember. If it's almost time for your next dose, skip the missed dose and continue your regular schedule. Avoid double doses.\n\nStorage: Keep REMINIL 1.25 in a cool, dry place, away from direct sunlight and out of reach of children.\n\n \n\nSide Effects:\n \nWhile REMINIL 1.25 is generally well-tolerated, some individuals may experience side effects, including:\n\nDizziness or lightheadedness, especially when standing up quickly\nCough: A persistent dry cough is a common side effect of ACE inhibitors.\nFatigue: Feeling tired or low energy can occur as your body adjusts to the medication.\nHeadache: Some individuals may experience mild headaches.", "price": 34.8, "discountamount": 10.44, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "next dose", "same time", "low energy", "blood flow", "double doses", "heart muscle", "Key Benefits", "Side Effects", "relaxed state", "heart disease", "heart attacks", "blood vessels", "ACE inhibitors", "mild headaches", "angiotensin II", "Heart Function", "direct sunlight", "cool, dry place", "regular schedule", "Kidney Protection", "reliable solution", "common side effect", "healthcare provider", "high blood pressure", "kidney complications", "ACE) inhibitor class", "persistent dry cough", "overall heart health", "blood pressure control", "long-term heart health", "consistent blood levels", "heart-related conditions", "angiotensin-converting enzyme", "other kidney-related concerns", "hypertension-related complications" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2000, "imageuri": "https://productimages.withfloats.com/actual/671b8c4e4131e87773887a28.png", "tileimageuri": "https://productimages.withfloats.com/tile/671b8c4e4131e87773887a28.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-10-25T12:17:15.486Z", "updatedon": "2024-10-25T12:17:15.486Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/ramipril-1-25-mg-/2000", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "REMINIL 1.25 ", "category": "CARDIOLOGYRANGE", "tags": [ "ramipril 1.25mg uses in hindi", "Ramipril 1.25 composition", "Is 1.25 mg of ramipril a low dose", "" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false } ], "hasmoreitems": false, "isapirequest": false, "totalresults": 27, "query": null, "floatingpoint": null }